Daiwa Securities Group Inc. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$60.0%3040.0%0.00%
Q2 2023$6
+20.0%
3040.0%0.00%
Q1 2023$5
-16.7%
3040.0%0.00%
Q4 2022$6
-99.8%
304
+39.4%
0.00%
Q3 2022$3,0000.0%2180.0%0.00%
Q2 2022$3,0000.0%2180.0%0.00%
Q1 2022$3,000
-40.0%
2180.0%0.00%
Q4 2021$5,000
-28.6%
2180.0%0.00%
Q3 2021$7,000
+40.0%
218
+81.7%
0.00%
Q2 2021$5,0000.0%1200.0%0.00%
Q1 2021$5,000
-16.7%
120
+15.4%
0.00%
Q4 2020$6,000
-14.3%
104
-66.9%
0.00%
Q3 2020$7,000
+75.0%
314
+10.6%
0.00%
Q2 2020$4,0000.0%2840.0%0.00%
Q1 2020$4,000
-33.3%
2840.0%0.00%
Q4 2019$6,000
+50.0%
284
-11.5%
0.00%
Q3 2019$4,0000.0%321
+16.3%
0.00%
Q2 2019$4,000
-20.0%
2760.0%0.00%
Q1 2019$5,000
-16.7%
276
-31.0%
0.00%
Q4 2018$6,0004000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders